Fresenius Medical Care FMS
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 21st percentile, 5-year average 17.8x
#1040 of 2996 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 18th percentile, 5-year average 0.9x
#1163 of 5338 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 8th percentile, 5-year average 0.6x
#1066 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 0.76 | – | 0.89 | 18% (cheaper than usual) | #1163 of 5338 (1 = cheapest) |
| PE | 12.51 | 11.36 | 17.81 | 21% (cheaper than usual) | #1040 of 2996 (1 = cheapest) |
| PS | 0.50 | 0.49 | 0.62 | 8% (cheaper than usual) | #1066 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on FMS.
Sign in to join the discussion.